For the first time in 40 years a new anti-tuberculosis drug with a novel mechanism of action has become available. Bedaquiline (BDQ) is a dia-rylquinoline antimycobacterial drug and specifically inhibits mycobacterial adenosine triphosphate syn-thase.
For more click here